The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality

Despite the rapid development of vaccines against COVID-19, they have important limitations, such as safety issues, the scope of their efficacy, and the induction of mucosal immunity. The present study proposes a potential component for a new generation of vaccines. The recombinant nucleocapsid (N)...

Full description

Bibliographic Details
Main Authors: Yadira Lobaina, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Alexis Musacchio, Ricardo Silva, Changyuan Tan, Alejandro Martín, Laura Lazo, Gerardo Guillén-Nieto, Ke Yang, Yasser Perera, Lisset Hermida
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Viruses
Subjects:
SARS-CoV-2
broad vaccine
intranasal
ODN
cell-mediated immunity
neutralizing Abs
Online Access:https://www.mdpi.com/1999-4915/16/3/418

Internet

https://www.mdpi.com/1999-4915/16/3/418

Similar Items